NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

35 hedge funds and large institutions have $31.1M invested in NeuBase Therapeutics, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$32K
Puts
$93K
Net Calls
Net Calls Change

Top Sellers

1 -$28K
2 -$27K
3 -$10.9K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$12.2M
2
$4.6M
3
$2.23M
4
$1.84M
5
$1.12M
6
$935K
7
$880K
8
$785K
9
$759K
10
$663K
11
$658K
12
$543K
13
$470K
14
$419K
15
$396K
16
$392K
17
$322K
18
$250K
19
$186K
20
$178K
21
$176K
22
$168K
23
$167K
24
$158K
25
$152K